Cargando…
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer
Toll-like receptor-9 (TLR9) is a member of the innate immune system and recognizes bacterial and vertebrate DNA in cells. In addition to being expressed in cells of the immune system, it is widely expressed in various types of human cancer, including prostate cancer. We have previously demonstrated...
Autores principales: | VÄISÄNEN, MARJA-RIITTA, JUKKOLA-VUORINEN, ARJA, VUOPALA, KATRI S., SELANDER, KATRI S., VAARALA, MARKKU H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678868/ https://www.ncbi.nlm.nih.gov/pubmed/23761830 http://dx.doi.org/10.3892/ol.2013.1204 |
Ejemplares similares
-
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
por: Ronkainen, Hanna, et al.
Publicado: (2011) -
Toll-Like Receptor 9 in Breast Cancer
por: Sandholm, Jouko, et al.
Publicado: (2014) -
Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo
por: Sandholm, Jouko, et al.
Publicado: (2016) -
CIP2A expression is increased in prostate cancer
por: Vaarala, Markku H, et al.
Publicado: (2010) -
Toll-Like Receptors in Esophageal Cancer
por: Kauppila, Joonas H., et al.
Publicado: (2014)